This session explores EMD’s new cross‑business initiative centered on Microphysiological Systems (MPS), cutting‑edge in vitro platforms that model human organ function to accelerate drug development and reduce animal testing. Sakshi will discuss how the initiative came to life, the strategies used to align multiple business units, and the practical lessons learned from driving collaboration at scale.